Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07467018 · ClinicalTrials.gov registry record
Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles County
A clinical trial, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- 100
- Enrollment target
NCT07467018 is a clinical trial that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 100 participants.
The verdict
NCT07467018 is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
This project evaluates the implementation strategy of the delivery of lenacapavir pre-exposure prophylaxis (LEN PrEP) - a newly available long-acting, injectable medication for human immunodeficiency virus (HIV) prevention - via a mobile health van model for people who are unstably housed in Los Angeles County (LAC). People who are unhoused or are facing housing instability experience significant barriers to accessing HIV prevention care in traditional clinic settings. In 2022, approximately 13% of newly diagnosed HIV cases in LAC were experiencing homelessness, a 36% increase over the prior period. The study will work with the University of California, Los Angeles (UCLA) Health's Homeless Healthcare Collaborative (HHC), which operates mobile health vans staffed by clinicians, social workers, and community health workers, to bring LEN PrEP directly to community settings, such as shelters, encampments, community centers, and transitional housing facilities. This study has three primary aims: 1. Characterize uptake of LEN PrEP among unstably housed people in LAC receiving health services via HHC's mobile program. 2. Evaluate how many study participants stay on LEN PrEP through 52 weeks. 3. Understand costs, acceptability, and sustainability of the mobile LEN PrEP delivery model.
Interventions
- DRUG Lenacapavir
- OTHER Community-based healthcare delivery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-04-21 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07467018
The ClinicalTrials.gov registry entry for NCT07467018 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lenacapavir is the first listed.
NCT07467018 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07467018 about?
NCT07467018 is a clinical study titled "Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles County". This project evaluates the implementation strategy of the delivery of lenacapavir pre-exposure prophylaxis (LEN PrEP) - a newly available long-acting, injectable medication for human immunodeficiency virus (HIV) prevention - via a mobile health van model for people who are unstably housed in Los Ang...
What is the current status of trial NCT07467018?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2026-04-21. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07467018?
The interventions under investigation include: Lenacapavir (DRUG), Community-based healthcare delivery (OTHER).
Who is sponsoring clinical trial NCT07467018?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.